The study investigates the safety and outcomes of percutaneous tracheostomy in COVID-19 patients experiencing prolonged respiratory failure.
A total of 24 patients were reviewed, with significant outcomes showing that 71% still had tracheostomy tubes and 58% remained on ventilation 30 days post-procedure; 13% died within that timeframe.
The findings suggest that percutaneous tracheostomy can be safely performed even in patients with morbid obesity and does not pose a risk of COVID-19 infection to healthcare providers involved in the procedure.